Laparoscopic Cholecystectomy Operative Time and Hospital Stay Differences Between Sicklers and Non-sicklers: A

Lamair A Albakri1,2, Reem A Algarni3,4, Rawan K Alrajhi5

  • 1Collage of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.

Cureus
|December 5, 2022
PubMed

Insights

Sickle cell disease (SCD) patients undergoing laparoscopic cholecystectomy (LC) have longer hospital stays. Standardizing preoperative care for SCD patients is crucial to improve outcomes and reduce hospitalization time.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Surgical Oncology

Background:

  • Sickle cell disease (SCD) is a leading cause of pigment gallstones.
  • Laparoscopic cholecystectomy (LC) is a safe treatment for gallstones in SCD patients.
  • Current preoperative preparation for SCD patients undergoing LC lacks standardized guidelines.

Purpose of the Study:

  • To compare preoperative, operative, postoperative, and total hospital stay durations for SCD and non-SCD patients undergoing LC.
  • To identify potential areas for improving peri-operative management in SCD patients.

Main Methods:

  • Retrospective comparative cross-sectional study of 793 LC patients (2013-2018).
  • Data collected included demographics, clinical presentation, admission type, and various hospitalization lengths.
  • Statistical analysis performed using JMP 15.2.1.

Main Results:

  • SCD patients experienced significantly longer preoperative, postoperative, and total hospital stays (p<0.001).
  • Operative time for LC did not significantly differ between SCD and non-SCD groups.
  • SCD patients constituted 2.018% of the total LC cohort.

Conclusions:

  • SCD is a significant risk factor for gallstone formation requiring LC.
  • Peri-operative management presents challenges for SCD patients undergoing LC.
  • Further research is needed to develop standardized peri-operative protocols for SCD patients to optimize care and reduce hospital stays.